Abstract
You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology IV (PD61)1 Apr 2020PD61-02 RE-TREATMENT FOR PERSISTENT LOWER URINARY TRACT SYMPTOMS AFTER CONVECTIVE WATER VAPOR THERMAL PROSTATE ABLATION Garrick Greear*, Thomas DiPina, and Seth Bechis Garrick Greear*Garrick Greear* More articles by this author , Thomas DiPinaThomas DiPina More articles by this author , and Seth BechisSeth Bechis More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000978.02AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Convective water vapor thermal prostate ablation is a minimally invasive treatment for lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH). We present data from a cohort of patients undergoing convective water vapor thermal treatment of the prostate who underwent additional treatment for relief of symptoms. METHODS: A retrospective review of patients treated with water vapor thermal therapy at a single institution from August 2017 to August 2019 was conducted. Patient demographics, relevant pre- and peri-operative data, and international prostate symptoms scores (IPSS) were evaluated. Patients who underwent a subsequent procedure were compared to the cohort who did not undergo re-treatment. Descriptive statistics and Student’s t-test were performed. RESULTS: Data from 136 consecutive patients undergoing water vapor thermal therapy were collected and analyzed. The re-treatment rate over the study period was 7.4% with a median follow up of 183 days (IQR 90.7 – 295). Longer follow up was observed in patients who underwent a subsequent procedure (median 331 days, IQR 208 – 332). Men in the re-treatment cohort tended to be older (73.0 vs. 66.7 yrs, p = 0.04). No difference in prostate size, baseline IPSS score, number of treatments, or the treatment of a median lobe appeared to be associated with re-treatment (Table 1). The modality of retreatment was: transurethral resection of prostate (n = 5), photo-vaporization (n = 3), sacral neuromodulation (1), simple prostatectomy (1). IPSS scores appeared to diverge from the main cohort around 6 months post-operatively (p < 0.02) (Table 2.). CONCLUSIONS: The re-treatment rate after water vapor thermal therapy for BPH is low. Men in this cohort tended to be older and worsening symptom scores were observed at 6 months post-operatively. These data can inform counseling as to the timing of re-intervention in men with persistent bothersome lower urinary tract symptoms following minimally invasive outlet reduction. Source of Funding: None © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1280-e1280 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Garrick Greear* More articles by this author Thomas DiPina More articles by this author Seth Bechis More articles by this author Expand All Advertisement PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have